Cartesian Therapeutics, Inc. RNAC
6.32 USD -0.17 -2.62%
As of Nov 2, 3:11 PM ET
- YTD
- -12.34%
- 1 year
- -22.64%
- Open
- 6.49
- Prev close
- 6.49
- Mkt cap
- 191.67M
- Vol
- 53.16K
- Avg vol
- 130.47K
- EPS
- -5.78
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.20
- High
- 6.68
- Forward P/E
- -5.54
- Beta
- 0.00
- Short ratio
- 15.83
- Inst. own
- 27.85%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 20.18
- 200-d avg
- 19.88
- 1y target
- 38.17
MAX chart
Chart tools
Chart is warming up
The all-time price history for RNAC has not been loaded yet. Try again in a moment.
Altman Z-Score
-4.60 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -1.4×
P/S 67.0×
P/B -1.5×
P/FCF -2.4×
EV/EBITDA -0.5×
EV/Sales 26.7×
FCF Yield -42.4%
Gross Margin 100.0%
Operating Margin -3099.9%
Net Margin -4658.6%
ROE 103.2%
ROIC -28.4%
ROA -44.0%
Revenue -92.8%
Operating Income -97.5%
EPS (diluted) -52.6%
Free Cash Flow -142.3%
Current Ratio 8.7×
Quick Ratio 8.7×
Debt / Equity -0.1×
Net Debt / EBITDA 0.8×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31